文献速递腹部技术与安全CT

单次扫描腹部多排CT的诊断效能:低剂量方案的前瞻性评估

Diagnostic efficacy of single-pass abdominal multidetector-row CT: prospective evaluation of a low dose protocol.
PubMed 文献 · Br J Radiol · 2016-11-09

前瞻性纳入65例非创伤性急性肠病患者,按年龄分两组采用低辐射高对比剂剂量方案行单次扫描增强多排CT。A组(20-44岁)敏感度91.3%、特异度90.9%、准确率91.1%,B组(45-70岁)分别为95.4%、88.8%、93.5%,两组间无显著差异;A组辐射剂量7.5±2.8 mSv、对比剂155±30 ml,B组分别为14.1±5.3 mSv、130±24 ml(P<0.001)。作者认为该方案在特定年轻患者中安全且剂量有效。

要点

  • A组敏感度91.3%、特异度90.9%,B组敏感度95.4%、特异度88.8%,组间比较P值分别为0.905和0.998。
  • A组辐射剂量7.5±2.8 mSv、对比剂155±30 ml,B组分别为14.1±5.3 mSv、130±24 ml,组间P<0.001。
  • A组患者4-6周随访甲状腺功能均无甲状腺毒症实验室证据。

核心结论

  • 低辐射高对比剂剂量方案在特定年轻非创伤性急性肠病患者中被证明是安全且剂量有效的检查方案。

研究设计与样本

  • 前瞻性研究纳入65例(男32例、女33例,年龄20-67岁)连续非创伤性急性肠病患者,行单次扫描增强多排CT,注射非离子碘对比剂(370 mgI/ml)后70-100秒扫描;按年龄分A组(20-44岁,n=34)和B组(45-70岁,n=31),A组噪声指数15、对比剂2.5 ml/kg,B组噪声指数12.5、对比剂2 ml/kg。

诊断标准与关键数值

  • A组敏感度91.3%、特异度90.9%、总诊断准确率91.1%;B组敏感度95.4%、特异度88.8%、总诊断准确率93.5%;敏感度组间P=0.905,特异度组间P=0.998,准确率组间P=0.756。

临床应用与阅片要点

  • 作者提出,对甲状腺和肾功能正常的年轻患者(<40岁)可安全给予增加的碘对比剂(0.7-0.9 gI/ml),以补偿标准滤波反投影算法低剂量CT方案所致的较低图像质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the diagnostic efficacy of single-pass contrast-enhanced multidetector CT (CE-MDCT) performed with a low-radiation high-contrast (LR-HC) dose protocol in selected patients with non-traumatic acute bowel disease.

METHODS: 65 (32 males, 33 females; aged 20-67 years) consecutive patients with non-traumatic acute bowel disease underwent single-pass CE-MDCT performed 70-100 s after i.v. bolus injection of a non-ionic iodinated contrast medium (CM) (370 mgI ml-1). In 46 (70%) patients with a clinical and/or ultrasonographic suspicion of inflammatory bowel disease, up to 1.2-1.4 l of a 7% polyethylene-glycol solution was orally administered 45-60 mins prior to the CT examination. Patients were then divided into two groups according to age: Group A (20-44 years; n = 34) and Group B (45-70 years; n = 31). Noise index (NI) and CM dose were selected as follows: Group A (NI = 15; 2.5 ml kg-1) and Group B (NI = 12.5; 2 ml kg-1). All patients of Group A underwent thyroid functional tests at 4-6 weeks. Final diagnoses were obtained by open (n = 12) or laparoscopic surgery (n = 4), endoscopy w/without biopsy (n = 24) and clinical (n = 19) and/or instrumental (ultrasonography) (n = 6) follow-up at 11 ± 4 months (range 6-18 mo.). Statistical analysis was performed by χ2 and Student's t-test for categorical and continuous variables, respectively.

RESULTS: Sensitivity and specificity were 91.3 vs 95.4% (p = 0.905) and 90.9 vs 88.8% (p = 0.998) with an overall diagnostic accuracy of 91.1 vs 93.5% (p = 0.756), whereas the radiation (in millisievert) and CM dose (in millilitre) were 7.5 ± 2.8 mSv and 155 ± 30 ml for Group A and 14.1 ± 5.3 mSv and 130 ± 24 ml for Group B (p < 0.001), respectively. No patients of Group A showed laboratory signs of thyrotoxicosis at follow-up.

CONCLUSION: The LR-HC has proved to be a safe and a dose-effective protocol in the evaluation of selected young patients with non-traumatic acute bowel disease. Advances in knowledge: (1) As reaching the highest diagnostic benefit to risk ratio (AHARA) appears to be the current principle of MDCT imaging, an increased amount of iodinated CM (0.7-0.9 gI ml-1) can be safely administered to young patients (<40 years) with normal thyroid and renal function to compensate for the lower image quality resulting from low-dose CT protocols performed with the standard filter back-projection algorithm. Such an approach will result in a significant reduction of the radiation dose, which could be otherwise achieved only using iterative reconstruction algorithms combined with either low tube voltage and/or low tube current protocols. (2) An optimal scan delay (Tdelay) for a venous phase caudocranial acquisition can be calculated by the following formula: Tdelay = CI + 25 - TSD, where CI is the duration of the contrast injection, 25 is the average of the sum of abdominal aortic and peak hepatic arrival times and TSD is the scan duration. With such an approach, the radiation exposure resulting from bolus tracking, albeit performed with low-dose scans, can be spared in patients with normal transit times.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Camera L, Liccardo I, Romano F, et al. Diagnostic efficacy of single-pass abdominal multidetector-row CT: prospective evaluation of a low dose protocol. Br J Radiol. 2016. PMID: 27826994. doi:10.1259/bjr.20160612

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。